Castle Biosciences CSTL Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's common stock, par value (in dollars per share)?
- Castle Biosciences (CSTL) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Castle Biosciences's common stock, par value (in dollars per share) changed year-over-year?
- Castle Biosciences's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Castle Biosciences's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Castle Biosciences's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.